Stay updated with breaking news from Peric Sim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
3 LinkedIn creators share their advice for young professionals and recent grads navigating the current job market.
Nirsevimab is the first investigational immunisation designed to protect all infants across the RSV season with a single dose - News - PharmaTimes
New nirsevimab data analyses reinforce efficacy against RSVA prespecified pooled analysis of Phase 3 and Phase 2b data demonstrated an efficacy of 79.5% against medically attended lower respiratory tract infections (LRTI), including hospitalizations, caused by respiratory syncytial virus (RSV)1Nirsevimab is the firs...
New nirsevimab data analyses reinforce efficacy against RSV A prespecified pooled analysis of Phase 3 and Phase 2b data demonstrated an efficacy of 79.5% against medically attended lower respiratory
Owners reduce bargaining sessions from give-and-take to take-and-take ... and want to shrink the minor leagues yet again.